The Global hepatitis report 2026 warns that viral hepatitis remains a leading global health problem, despite the availability of a highly effective hepatitis B vaccine since the 1990s, effective antiviral treatments for chronic hepatitis B infection and, since 2015, a 12-week antiviral treatment for hepatitis C infection that has a 95% cure rate. To achieve the 2030 global targets, the …